Details for 2018709192

Up to date per 04.04.2026

Actions

Title / Product Name

KOMBINIERUNGEN AUS CABOZANTINIB UND ATEZOLIZUMAB ZUR BEHANDLUNG DER KASTRATION-RESISTANTEN PROSTATAKREBS

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2018709192

EP Publication Number

3570840

E-Number

1776391

Language

PCT Number

US18014523

Publication Date

27.11.2019 A

19.03.2025 B1

Registration Date

19.03.2025

AT Publication Date

15.04.2025

Application Date

19.01.2018

Registration Number

Priorities

20.01.2017

201762448869 P

13.02.2017

201762458447 P

IPC

A61K 31/47 20060101AFI20231122BHEP

Maximum Duration of Protection

19.01.2038

Owner

Exelixis, Inc.1851 Harbor Bay Parkway Alameda, CA 94502US

Representative

No representatives present

Inventor

SCHWAB, Gisela25530 Dario Terrace Hayward CA 94541US

SCHEFFOLD, Christian642 Maybell Avenue Palo Alto CA 94306US

HESSEL, Colin17 Inyo Pl. Redwood City CA 94061US